sort of mental health problems that make have arisen from childhood or arising from depression or loneliness or harsh lives, so we have to understand that is where addiction comes from. you mentioned 300,000 registered people who have drug or, cocaine or opiate problems but that many other hundreds of thousands addicted to other substances or behaviours like gambling. they are not all moral degenerates and outsider in society. they are people struggling with a health condition and we should respond with care and compassion and treatment of. respond with care and compassion and treatment of- treatment of. addiction is a health condition, that treatment of. addiction is a health condition, that is how treatment of. addiction is a health condition, that is how we - treatment of. addiction is a health condition, that is how we should i condition, that is how we should approach it. condition, that is how we should approach it condition, that is how we should a- roach it. ~ , , ., ., a
used. ., , , treatment of, i regret the language used. . , , ., used. has there ever been a satisfactory used. has there ever been a satisfactory explanation - used. has there ever been a | satisfactory explanation from used. has there ever been a - satisfactory explanation from martin bashir satisfactory explanation from martin bashir and stir fry he had these bank bashir and stir fry he had these bank statements made up but couldn t it have bank statements made up but couldn t it have been and did it ever cross your it have been and did it ever cross your mind it have been and did it ever cross your mind that will sponsor and the princess your mind that will sponsor and the princess of your mind that will sponsor and the princess of wales were concerned that they princess of wales were concerned that they may be princess of wales were concerned that they may he being conspired against, that they may he being conspired against, that these documents could be used again
For treatment of HER2 positive Breast CancerZydus Cadila launched Trastuzumab Emtansine, the first Antibody Drug Conjugate (ADC) biosimilar and a highly effective drug for treating both Early and Advanced HER2 positive Breast Cancer, under the brand name Ujvira . HER2 positive Breast Cancer is considered an aggressive form and constitutes 20 to 25% of all Breast Cancer.
In a step that can significantly reduce treatment cost by almost 80%, the drug is being offered at Rs. 32495 for a 100 mg vial. The current MRP of existing Trastuzumab Emtansine drug is Rs. 1,59,225 for 100 mg vial. Ujvira will be available in two strengths, 100 mg and 160 mg.
Powered by Capital Market - Live News
Natco Pharma jumped 6.2% to Rs 884.35 after the company received final approval for everolimus tablets in the US market.Natco Pharma announced that its marketing partner, Breckenridge Pharmaceutical Inc. (BPI), has received final approval for its abbreviated new drug application (ANDA) for everolimus tablets (a generic version of Afinitor) from the US Food and Drug Administration (USFDA).
BPI plans to launch 2.5 mg, 5 mg and 7.5 mg strengths of the product shortly within the next few weeks. The launch of 10mg strength of the product is subject to confidential terms of a settlement and license agreement entered into with the owner of the Afinitor brand. The launch date of 10mg strength of the product will be announced at a later date.
The drug major has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan nasal spray, 20 mg from the United States Food and Drug Administration (USFDA).
The product is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline s Imitrex nasal spray. Imitrex is a serotonin (5-HT1B/1D) receptor agonist (triptan) indicated for acute treatment of migraine with or without aura in adults.
According to IQVIA (IMS Health), Imitrex nasal spray 20 mg and its generic equivalents had US sales of approximately $53.3 million for the 12-month period ending December 2020.
Separately, Cipla announced that its subsidiary, Cipla Gulf FZ LCC, is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.